# Implantation or Injectable Dosage Form New Animal Drugs; Oxytetracycline Hydrochloride Injection
> **US Department of Health and Human Services** · Final rule. · Published 1997-03-26 · Effective 1997-03-26 · 62 FR 14302
## Document
- **Document number:** 97-7542
- **Category:** other
- **Sub-agency:** US Department of Health and Human Services
- **Federal Register citation:** 62 FR 14302
- **CFR reference:** 21 CFR 522
- **Publication date:** 1997-03-26
- **Effective date:** 1997-03-26
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Boehringer Ingelheim Animal Health, Inc. The supplemental NADA provides for the subcutaneous use (in addition to the approved intravenous and intramuscular use) of 100 milligrams/ milliliter (mg/mL) of oxytetracycline hydrochloride injection in cattle for the treatment of diseases caused by oxytetracycline susceptible organisms, for a 2-day withdrawal period following the subcutaneous use, and for a 13-day withdrawal period following the intramuscular and intravenous use.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1997/03/26/97-7542/implantation-or-injectable-dosage-form-new-animal-drugs-oxytetracycline-hydrochloride-injection)
---
*AI Analytics · CC0 1.0*